Home > Journals > Biology and research > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Biology and research
Journal de Pharmacie Clinique
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Interaction between fumagillin and tacrolimus in a kidney transplant recipient


Journal de Pharmacie Clinique. Volume 25, Number 4, 248-50, Décembre 2006, Article original

Résumé   Article gratuit  

Author(s) : H Michelon, H Sterlingot, N Arzouk, AM Taburet, A Durrbach, V Furlan

Summary : Fumagillin, antibiotic derived from A. fumigatus, is a new treatment for chronic E. bieneusi infection in immunocompromised patients. The pharmacokinetic properties and drug-drug interaction with substrate of cytochrome P450 3A4 and/or P-glycoprotein (Pgp) are presently unknown. We report the case of a renal transplant recipient who was in a stable regimen tacrolimus and developed diarrhoeas due to microsporidiosis treated by fumagillin. A decrease in tacrolimus whole blood concentration by 50% was observed after starting fumagillin. Tacrolimus pharmacokinetic study before and after initiation of fumagillin showed a decrease in tacrolimus ASC by 32% and an increase Cl/F by 46%. An induction of tacrolimus metabolic enzymes or transporters by fumagillin is the likely mechanism of this interaction. A close monitoring of tacrolimus concentrations and frequent dose adjustments may be required whether fumagillin is administered in patients who receive tacrolimus.

Keywords : fumagillin, tacrolimus, interaction, renal transplantation, microsporidiosis

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]